Monash IVF logo

MVF - Monash IVF Share Price

A$0.795 -0.0  -0.6%

Last Trade - 5:10am

Sector
Healthcare
Size
Small Cap
Market Cap £175.6m
Enterprise Value £200.9m
Revenue £81.9m
Position in Universe 494th / 1835
Bullish
Bearish
Unlock MVF Revenue
Momentum
Relative Strength (%)
1m +12.0%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -10.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
125 156.6 155.2 150.6 152 145.4 166.1 168 +3.1%
+93.2 +22.3 +3.0 -27.7 -2.2 -36.9 -4.25 +12.0
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 30 June 2020, Monash IVFGroup Ltd revenues decreased 4% to A$145.4M. Net incomedecreased 41% to A$11.7M. Revenues reflect Monash IVF Group-Australia segment decrease of 3% to A$135.5M, Surgeries -Monash IVF Group Australia decrease of 6% to 13K. Netincome also reflects Other expenses increase of 31% toA$5.3M (expense). Dividend per share decreased from A$0.06to A$0.02.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

MVF Revenue Unlock MVF Revenue

Net Income

MVF Net Income Unlock MVF Revenue

Normalised EPS

MVF Normalised EPS Unlock MVF Revenue

PE Ratio Range

MVF PE Ratio Range Unlock MVF Revenue

Dividend Yield Range

MVF Dividend Yield Range Unlock MVF Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
MVF EPS Forecasts Unlock MVF Revenue
Profile Summary

Monash IVF Group Limited is engaged in the provision of assisted reproductive services. The Company is also engaged in the provision of women's imaging and diagnostic services in Australia and Malaysia. The Company's segments include Monash IVF Group Australia and Monash IVF Group International. The Monash IVF Group Australia segment is a provider of assisted reproductive services, ultrasound and other related services. The Monash IVF Group International segment is a provider of assisted reproductive services in Malaysia. The Company offers a range of specialist diagnostic obstetric and gynecological ultrasound and fertility treatments. The Company's business includes Bump, KL Fertility, Monash Ultrasound for Women, MyIVF Clinic, Next Generation Fertility, Reproductive Medicine Albury, Reproductive Medicine Wagga, Repromed and Sydney Ultrasound for Women. Bump provides patients with a personalized online application tool, iBUMP.

Directors
Last Annual June 30th, 2020
Last Interim June 30th, 2020
Incorporated April 30, 2014
Public Since June 25, 2014
No. of Shareholders: 6,843
No. of Employees: 590
Sector Healthcare
Industry Healthcare Providers & Services
Index S&P/ASX All Ordinaries , S&P/ASX 300 , ASX Small Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 389,634,840
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MVF Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MVF
Upcoming Events for MVF
Frequently Asked Questions for Monash IVF
What is the Monash IVF share price?

As of 5:10am, shares in Monash IVF are trading at A$0.795, giving the company a market capitalisation of £175.6m. This share price information is delayed by 15 minutes.

How has the Monash IVF share price performed this year?

Shares in Monash IVF are currently trading at A$0.795 and the price has moved by -10.3% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Monash IVF price has moved by -14.28% over the past year.

What are the analyst and broker recommendations for Monash IVF?

Of the analysts with advisory recommendations for Monash IVF, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Monash IVF is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Monash IVF next release its financial results?

Monash IVF is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Monash IVF dividend yield?

The Monash IVF dividend yield is 2.45% based on the trailing twelve month period.

Does Monash IVF pay a dividend?

Last year, Monash IVF paid a total dividend of 0.02, and it currently has a trailing dividend yield of 2.45%. Looking ahead, shares in Monash IVF are due to go ex-dividend on 2021-03-09 and the next dividend pay date is 2021-04-07.

When does Monash IVF next pay dividends?

Monash IVF are due to go ex-dividend on 2021-03-09 and the next dividend pay date is 2021-04-07. The historic dividend yield on Monash IVF shares is currently 2.45%.

How do I buy Monash IVF shares?

To buy shares in Monash IVF you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Monash IVF?

Shares in Monash IVF are currently trading at A$0.795, giving the company a market capitalisation of £175.6m.

Where are Monash IVF shares listed? Where are Monash IVF shares listed?

Here are the trading details for Monash IVF:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: MVF
What kind of share is Monash IVF?

Based on an overall assessment of its quality, value and momentum, Monash IVF is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Monash IVF share price forecast 2021?

Shares in Monash IVF are currently priced at A$0.795. At that level they are trading at 19.13% discount to the analyst consensus target price of 0.00.

Analysts covering Monash IVF currently have a consensus Earnings Per Share (EPS) forecast of 0.05 for the next financial year.

How can I tell whether the Monash IVF share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Monash IVF. Over the past six months, the relative strength of its shares against the market has been 11.62%. At the current price of A$0.795, shares in Monash IVF are trading at 23.98% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Monash IVF PE Ratio?

The Monash IVF PE ratio based on its reported earnings over the past 12 months is 15.32. The shares are currently trading at A$0.795.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Monash IVF?

Monash IVF's management team is headed by:

Richard Davis - NEC
Josef Czyzewski - NID
Neil Broekhuizen - NID
Richard Henshaw - EDR
Michael Knaap - CEO
Zita Peach - NID
Tedd Fuell - OTH
Hamish Hamilton - COO
Malik Jainudeen - CFO
Johannes Lagerwij - OTH
Loke May Kew - OTH
Pierre Haila - CIO
Peggy North - OTH
Fiona Allen - CMO
Catherine West - NID
Who are the major shareholders of Monash IVF?

Here are the top five shareholders of Monash IVF based on the size of their shareholding:

BlackRock Investment Management (Australia) Ltd. Investment Advisor
Percentage owned: 13.34% (52.0m shares)
Allan Gray Australia Pty Ltd Investment Advisor
Percentage owned: 13.31% (51.9m shares)
Challenger Managed Investments Ltd. Investment Advisor
Percentage owned: 7.87% (30.7m shares)
Lennox Capital Partners Pty Ltd. Investment Advisor
Percentage owned: 7.35% (28.6m shares)
Argo Investments Limited Investment Advisor
Percentage owned: 5.13% (20.0m shares)
Similar to MVF
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.